Broadway's Week: $38M Gross Trails Last Year by $5.3M as 40 Shows Fill 86% of Seats
For the week ending May 17, 2026, Broadway's 40 active shows combined for $38,166,526.86 in gross receipts, a $5,334,903.42 gap below the same week in 2025. A single show, Every Brilliant Thing, averaged $250.62 per ticket while Celebrity Autobiography averaged $15.22, a 16-to-1 price spread across the same Broadway marquee. Season-to-date, the 2025–2026 season has outpaced the prior season at the same point by $78,253,554.88 across 50 weeks.
Stage Door Society's analysis of Broadway's financial performance examines the revenue dynamics and pricing strategies that shape the commercial theater market week by week. By tracking gross receipts, attendance patterns, and per-ticket pricing across the active Broadway roster, the research illuminates how individual shows compete for audience dollars and how aggregate box-office health fluctuates against historical benchmarks. This granular view reveals both the resilience and volatility of Broadway's revenue streams during a given season.
Understanding these metrics matters because Broadway's financial performance signals broader health in the live performing-arts ecosystem. Shifts in weekly grosses, seat-fill rates, and pricing power across shows of different scales and genres reflect audience demand, production economics, and the competitive landscape that producers and theater operators navigate. For industry stakeholders—from producers and investors to arts organizations tracking the sector—these patterns offer insight into what drives attendance and revenue in a market where a single show's pricing strategy can diverge dramatically from its neighbors.
Financial and compensation data is sourced from public filings and reports. This content is for informational purposes only and does not constitute financial, investment, or professional advice. Past figures do not indicate future performance. See disclaimer.